Biomedical Catalyst

AMBER Tx General

Strategy Notes

The programme is UK-focused, while the venture targets EU/France primarily. However, the technology's application to drug resistance and chronic conditions aligns well, and the grant size is attractive. The venture would need a UK entity or partner to apply.

Key Materials

—

Your Notes

Status & Deadline

Status: INELIGIBLE
Deadline: rolling
Cycle: rolling
Amount: up to £2.5M
Type: grant
URL: Apply

Update Status

Log Application

AI Pipeline

Research Programme Generate Draft

Status History

2026-07-31 OPEN → INELIGIBLE · The programme requires the applicant to be a UK-based start-up or have a UK entity/partner. The applicant is an independent researcher based in Nigeria/Germany with no UK entity or partner, and the venture targets EU/France primarily.